Abstract
Background/Aim. Matrix metalloproteinase-9 (MMP-9) index is the ratio of active MMP-9 and total MMP-9 levels. It reflects the importance of MMP-9 in acute coronary syndrome (ACS). Methods. The study included 3 groups of patients (n = 87): the group 1 – non-diabetic subjects without ACS (control); the group 2 – diabetic patients with ACS [subgroups with unstable angina pectoris (UAP), myocardial infarction (MI) or reinfarction]; and the group 3 non-diabetics patients with ACS. Total and active MMP-9 were measured and used to create MMP-9 index. Results. MMP-9 index, as a marker showed good sensitivity and specificity, of ACS in diabetics, with a cut-off value over 58.2. MMP-9 was higher in the study groups than in the control one. MMP-9 correlated with ACS occurrence and type of cardiovascular event. A statistically significant difference was found among the groups according to active MMP-9 (p < 0.001). The same was found with active MMP-9 between the control and the group with MI (p < 0.001). The control was highly statistically significantly different from the group of patients with UAP (p < 0.01). Statically significant differences in MMP-9 index was found between the control and the diabetics with ACS (p < 0.001). Statistically significant difference of MMP-9 index was also found in the controls compared to the value in non-diabetic patients with ACS (p < 0.01). Conclusion. MMP-9 index may be a possible marker of atheromatous plaque rupture in diabetics.
Keywords
acute coronary syndrome
matrix metalloproteinase 9
prognosis
References
Cola C, Clementi E, Biondi-Zoccai G, Sangiorgi G. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events. Acta Chir Belg 2007; 107(2): 129−42.
Fingleton B. Matrix metalloproteinases as valid clinical targets. Curr Pharm Des 2007; 13(3): 333−46.
Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Bi-ol 2007; 8(3): 221−33.
Dabek J, Kulach A, Gasior Z. The role of matrix metalloprotei-nases in acute coronary syndromes. Eur J Int Med 2007; 18(6): 463−6.
Hansson GK. Inflammation, atherosclerosis, and coronary ar-tery disease. N Engl J Med 2005; 352(16): 1685−95.
Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovas-cular disease. Circulation 2003; 107(12): 1579−85.
Newby AC. Do metalloproteinases destabilize vulnerable athe-rosclerotic plaques. Curr Opin Lipidol 2006; 17(5): 556−61.
Tayebjee MH, Lip GY, MacFadyen RJ. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. Curr Med Chem 2005; 12(8): 917−25.
Kameda K, Matsunaga T, Abe N, Fujiwara T, Hanada H, Fukui K, et al. Increased pericardial fluid level of matrix metalloprotei-nase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture. Circ J 2006; 70(6): 673−8.
Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006; 12(1): 66−72.
Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003; 59(4): 812−23.
Tsuzuki M, Morishima I, Yoshida T, Hayashi Y, Miura M, Hirai T, et al. Inverse correlation between soluble CD40 ligand and so-luble CD40 is absent in patients with unstable angina. Heart Vessels 2005; 20(6): 245−50.
Fiotti N, Altamura N, Orlando C, Simi L, Reimers B, Pascotto P, et al Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. Int J Cardiol 2008; 127(3): 350−7.
American Diabetes Association. Diagnosis and classification of di-abetes mellitus. Diabetes Care 2010; 33(Suppl 1): S62−9.
Verheijen JH, Nieuwenbroek NM, Beekman B, Hanemaaijer R, Verspaget HW, Ronday HK, et al. Modified proenzymes as artifi-cial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity us-ing modified pro-urokinase. Biochem J 1997; 323(3): 603−9.
Zeng B, Prasan A, Fung KC, Solanki V, Bruce D, Freedman SB, et al. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Intern Med J 2005; 35(6): 331−5.
Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, et al. Comparison of levels of serum matrix metallo-proteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006; 97(2): 175−80.
Lindsey ML. MMP induction and inhibition in myocardial in-farction. Heart Fail Rev 2004; 9(1): 7−19.
Vanhoutte D, Schellings M, Pinto Y, Heymans S. Relevance of ma-trix metalloproteinases and their inhibitors after myocardial in-farction: a temporal and spatial window. Cardiovasc Res 2006; 69(3): 604−13.
Maekawa K, Tsujino T, Saito K, Kim JI, Ikeda Y, Emoto N, et al. Inhibitory effect of insulin on vasopressin-induced intracellular calcium response is blunted in hyperinsulinemic hypertensive patients: role of membrane fatty acid composition. Heart Ves-sels 2006; 21(4): 205−12.
Aljada A, Ghanim H, Mohanty P, Syed T, Bandyopadhyay A, Dan-dona P. Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expres-sion of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations. Am J Clin Nutr 2004; 80(1): 51−7.
Baugh MD, Gavrilovic J, Davies IR, Hughes DA, Sampson MJ. Mo-nocyte matrix metalloproteinase production in Type 2 diabetes and controls - a cross sectional study. Cardiovasc Diabetol 2003; 2: 3.
Gostiljac D, Dorđević PB, Djurić D, Peruničić J, Lasica R, Colak E, et al. The importance of defining serum MMP-9 concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome. Acta Physiol Hung 2011; 98(1): 91−7.